Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07462273Not ApplicableCompleted

RISS Block for Enhanced Recovery After Video-Assisted Thoracoscopic Surgery

Role: lead

NCT07415070Not ApplicableNot Yet Recruiting

Effectiveness of Targeted Cervical Length Screening Guided by a Preterm Birth Risk Scoring System in Reducing the Rate of Preterm Birth

Role: lead

NCT06422130Active Not Recruiting

Ningbo Maternity-Child Linked Database Study

Role: lead

NCT06370793Active Not Recruiting

Ningbo Schizophrenia Cohort

Role: lead

NCT06374732Not ApplicableCompleted

The Benefits of a High-intensity Interval Training Intervention Delivered in a School Setting Among Adolescents

Role: collaborator

NCT06936033Not ApplicableCompleted

Kinesiology Taping and Ankle Stability in Acute Injuries During Stair Descent

Role: lead

NCT06641479Active Not Recruiting

JiAngSu Maternal and INfant HEalth Database

Role: collaborator

NCT02647515Phase 4Completed

Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma

Role: collaborator

All 8 trials loaded